OBJECTIVE: To analyze the clinical variants, outcomes, and prognosis of Guillain-Barré syndrome (GBS) in a Brazilian population. MATERIALS AND METHODS: Clinical and laboratory data of 149 cases of GBS diagnosed from 1994 to 2007 were analyzed. RESULTS: Acute inflammatory demyelinating polyneuropathy (AIDP) was the most frequent variant (81.8%) of GBS, followed by acute motor axonal neuropathy (AMAN) (14.7%) and acute motor and sensory axonal neuropathy (AMSAN) (3.3%). The incidence of GBS was 0.3/100,000 for the state of Rio Grande do Norte and cases occurred at a younger age. GBS was preceded by infections, with the axonal variant associated with episodes of diarrheas (P = 0.025). Proximal weakness was more frequent in AIDP, and distal weakness predominant in the axonal variant. Compared to 42.4% of cases with AIDP (P < 0.0001), 84.6% of cases with the axonal variant had nadir in <10 days. Individuals with the axonal variant took longer to recover deambulation (P < 0.0001). The mortality of GBS was 5.3%. CONCLUSION: A predominance of the AIDP variant was seen, and the incidence of the disease decreased with age. As expected, the distribution of weakness correlated with the clinical variants, and individuals with the axonal variant had a poorer prognosis.
OBJECTIVE: To analyze the clinical variants, outcomes, and prognosis of Guillain-Barré syndrome (GBS) in a Brazilian population. MATERIALS AND METHODS: Clinical and laboratory data of 149 cases of GBS diagnosed from 1994 to 2007 were analyzed. RESULTS: Acute inflammatory demyelinating polyneuropathy (AIDP) was the most frequent variant (81.8%) of GBS, followed by acute motor axonal neuropathy (AMAN) (14.7%) and acute motor and sensory axonal neuropathy (AMSAN) (3.3%). The incidence of GBS was 0.3/100,000 for the state of Rio Grande do Norte and cases occurred at a younger age. GBS was preceded by infections, with the axonal variant associated with episodes of diarrheas (P = 0.025). Proximal weakness was more frequent in AIDP, and distal weakness predominant in the axonal variant. Compared to 42.4% of cases with AIDP (P < 0.0001), 84.6% of cases with the axonal variant had nadir in <10 days. Individuals with the axonal variant took longer to recover deambulation (P < 0.0001). The mortality of GBS was 5.3%. CONCLUSION: A predominance of the AIDP variant was seen, and the incidence of the disease decreased with age. As expected, the distribution of weakness correlated with the clinical variants, and individuals with the axonal variant had a poorer prognosis.
Authors: María P Mahecha; Ernesto Ojeda; Daniel A Vega; Juan C Sarmiento-Monroy; Juan-Manuel Anaya Journal: Immunol Res Date: 2017-02 Impact factor: 2.829
Authors: Kattiucy Gabrielle da Silva Brito; Edarlan Barbosa Dos Santos; Liliane Dos Santos Maia Lucas; Marco Orsini; Rossano Fiorelli; Silmar Teixeira; Carla Ayres; Luan Correia; Victor Hugo Bastos; Eduardo Trajano; Carlos Eduardo Cardoso; Marcos R G de Freitas; Antônio Marcos da Silva Catharino Journal: Neurol Int Date: 2018-07-04
Authors: Safiyyah Asiri; Waleed A Altwaijri; Duaa Ba-Armah; Ahmed Al Rumayyan; Muhammad T Alrifai; Mahmoud Salam; Adel F Almutairi Journal: Neuropsychiatr Dis Treat Date: 2019-03-01 Impact factor: 2.570
Authors: Sonja E Leonhard; Melissa R Mandarakas; Francisco A A Gondim; Kathleen Bateman; Maria L B Ferreira; David R Cornblath; Pieter A van Doorn; Mario E Dourado; Richard A C Hughes; Badrul Islam; Susumu Kusunoki; Carlos A Pardo; Ricardo Reisin; James J Sejvar; Nortina Shahrizaila; Cristiane Soares; Thirugnanam Umapathi; Yuzhong Wang; Eppie M Yiu; Hugh J Willison; Bart C Jacobs Journal: Nat Rev Neurol Date: 2019-09-20 Impact factor: 42.937
Authors: Ashley R Styczynski; Juliane M A S Malta; Elisabeth R Krow-Lucal; Jadher Percio; Martha E Nóbrega; Alexander Vargas; Tatiana M Lanzieri; Priscila L Leite; J Erin Staples; Marc X Fischer; Ann M Powers; Gwong-Jen J Chang; P L Burns; Erin M Borland; Jeremy P Ledermann; Eric C Mossel; Lawrence B Schonberger; Ermias B Belay; Jorge L Salinas; Roberto D Badaro; James J Sejvar; Giovanini E Coelho Journal: PLoS Negl Trop Dis Date: 2017-08-30